Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

ATPC vs NHTC vs CLPS vs USNA vs NUS

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
ATPC
Agape ATP Corporation

Packaged Foods

Consumer DefensiveNASDAQ • MY
Market Cap$136M
5Y Perf.-100.0%
NHTC
Natural Health Trends Corp.

Specialty Retail

Consumer CyclicalNASDAQ • HK
Market Cap$36M
5Y Perf.-56.8%
CLPS
CLPS Incorporation

Information Technology Services

TechnologyNASDAQ • HK
Market Cap$25M
5Y Perf.-68.7%
USNA
USANA Health Sciences, Inc.

Packaged Foods

Consumer DefensiveNYSE • US
Market Cap$359M
5Y Perf.-79.4%
NUS
Nu Skin Enterprises, Inc.

Household & Personal Products

Consumer DefensiveNYSE • US
Market Cap$345M
5Y Perf.-82.3%

ATPC vs NHTC vs CLPS vs USNA vs NUS — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
ATPC logoATPC
NHTC logoNHTC
CLPS logoCLPS
USNA logoUSNA
NUS logoNUS
IndustryPackaged FoodsSpecialty RetailInformation Technology ServicesPackaged FoodsHousehold & Personal Products
Market Cap$136M$36M$25M$359M$345M
Revenue (TTM)$1M$38M$299M$925M$1.49B
Net Income (TTM)$-3M$-1M$-4M$11M$160M
Gross Margin52.7%73.8%22.8%76.6%69.4%
Operating Margin-189.0%-5.1%-1.4%5.5%4.4%
Forward P/E10.9x7.2x
Total Debt$363K$3M$34M$14M$364M
Cash & Equiv.$2M$7M$28M$158M$239M

ATPC vs NHTC vs CLPS vs USNA vs NUSLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

ATPC
NHTC
CLPS
USNA
NUS
StockSep 21May 26Return
Agape ATP Corporati… (ATPC)1000.0-100.0%
Natural Health Tren… (NHTC)10043.2-56.8%
CLPS Incorporation (CLPS)10031.3-68.7%
USANA Health Scienc… (USNA)10020.6-79.4%
Nu Skin Enterprises… (NUS)10017.7-82.3%

Price return only. Dividends and distributions are not included.

Quick Verdict: ATPC vs NHTC vs CLPS vs USNA vs NUS

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: NUS leads in 4 of 7 categories (5-stock set), making it the strongest pick for valuation and capital efficiency and profitability and margin quality. CLPS Incorporation is the stronger pick specifically for growth and revenue expansion and capital preservation and lower volatility. NHTC also leads in specific categories worth noting. This set spans 3 sectors — these stocks serve different portfolio roles, not just different price points.
ATPC
Agape ATP Corporation
The Lower-Volatility Pick

ATPC lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: consumer defensive exposure
NHTC
Natural Health Trends Corp.
The Long-Run Compounder

NHTC ranks third and is worth considering specifically for long-term compounding and sleep-well-at-night.

  • -63.6% 10Y total return vs NUS's -48.8%
  • Lower volatility, beta 0.58, Low D/E 13.4%, current ratio 2.50x
  • Beta 0.58, yield 25.0%, current ratio 2.50x
  • 25.0% yield, vs CLPS's 14.6%, (2 stocks pay no dividend)
Best for: long-term compounding and sleep-well-at-night
CLPS
CLPS Incorporation
The Income Pick

CLPS is the #2 pick in this set and the best alternative if income & stability and growth exposure is your priority.

  • Dividend streak 3 yrs, beta 0.27, yield 14.6%
  • Rev growth 15.2%, EPS growth -181.4%, 3Y rev CAGR 2.7%
  • 15.2% revenue growth vs NUS's -14.3%
  • Beta 0.27 vs NUS's 1.49
Best for: income & stability and growth exposure
USNA
USANA Health Sciences, Inc.
The Value Angle

Among these 5 stocks, USNA doesn't own a clear edge in any measured category.

Best for: consumer defensive exposure
NUS
Nu Skin Enterprises, Inc.
The Value Play

NUS carries the broadest edge in this set and is the clearest fit for value and quality.

  • Lower P/E (7.2x vs 10.9x)
  • 10.8% margin vs ATPC's -183.0%
  • +26.3% vs ATPC's -96.8%
  • 11.3% ROA vs ATPC's -11.1%, ROIC 7.3% vs -16.2%
Best for: value and quality
See the full category breakdown
CategoryWinnerWhy
GrowthCLPS logoCLPS15.2% revenue growth vs NUS's -14.3%
ValueNUS logoNUSLower P/E (7.2x vs 10.9x)
Quality / MarginsNUS logoNUS10.8% margin vs ATPC's -183.0%
Stability / SafetyCLPS logoCLPSBeta 0.27 vs NUS's 1.49
DividendsNHTC logoNHTC25.0% yield, vs CLPS's 14.6%, (2 stocks pay no dividend)
Momentum (1Y)NUS logoNUS+26.3% vs ATPC's -96.8%
Efficiency (ROA)NUS logoNUS11.3% ROA vs ATPC's -11.1%, ROIC 7.3% vs -16.2%

ATPC vs NHTC vs CLPS vs USNA vs NUS — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

ATPCAgape ATP Corporation
FY 2024
Product Health Therapies
78.4%$913,297
Health and Wellness Services
17.8%$207,546
Energized Mineral Concentrate
3.7%$43,487
Ionized Cal Mag
0.0%$388
NHTCNatural Health Trends Corp.
FY 2019
Product
92.3%$73M
Shipping and Handling
7.7%$6M
CLPSCLPS Incorporation
FY 2025
Other Member
100.0%$894,598
USNAUSANA Health Sciences, Inc.
FY 2025
All Other
100.0%$18M
NUSNu Skin Enterprises, Inc.
FY 2025
Manufacturing Segment
91.6%$206M
Rhyz Other Segment
7.9%$18M
Nu Skin
0.5%$1M

ATPC vs NHTC vs CLPS vs USNA vs NUS — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLUSNALAGGINGCLPS

Income & Cash Flow (Last 12 Months)

NUS leads this category, winning 3 of 6 comparable metrics.

NUS is the larger business by revenue, generating $1.5B annually — 1000.2x ATPC's $1M. NUS is the more profitable business, keeping 10.8% of every revenue dollar as net income compared to ATPC's -183.0%. On growth, CLPS holds the edge at +15.3% YoY revenue growth, suggesting stronger near-term business momentum.

MetricATPC logoATPCAgape ATP Corpora…NHTC logoNHTCNatural Health Tr…CLPS logoCLPSCLPS IncorporationUSNA logoUSNAUSANA Health Scie…NUS logoNUSNu Skin Enterpris…
RevenueTrailing 12 months$1M$38M$299M$925M$1.5B
EBITDAEarnings before interest/tax-$3M-$2M-$1M$91M$118M
Net IncomeAfter-tax profit-$3M-$1M-$4M$11M$160M
Free Cash FlowCash after capex-$3M-$6M$0$9M$46M
Gross MarginGross profit ÷ Revenue+52.7%+73.8%+22.8%+76.6%+69.4%
Operating MarginEBIT ÷ Revenue-189.0%-5.1%-1.4%+5.5%+4.4%
Net MarginNet income ÷ Revenue-183.0%-3.0%-1.3%+1.2%+10.8%
FCF MarginFCF ÷ Revenue-192.1%-16.5%-2.3%+0.9%+3.1%
Rev. Growth (YoY)Latest quarter vs prior year+11.9%-14.3%+15.3%+5.9%-16.9%
EPS Growth (YoY)Latest quarter vs prior year+92.3%-2.4%+75.8%-142.2%+139.7%
NUS leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

Evenly matched — CLPS and NUS each lead in 2 of 6 comparable metrics.

At 2.2x trailing earnings, NUS trades at a 93% valuation discount to USNA's 33.6x P/E. On an enterprise value basis, USNA's 2.4x EV/EBITDA is more attractive than NUS's 3.3x.

MetricATPC logoATPCAgape ATP Corpora…NHTC logoNHTCNatural Health Tr…CLPS logoCLPSCLPS IncorporationUSNA logoUSNAUSANA Health Scie…NUS logoNUSNu Skin Enterpris…
Market CapShares × price$136M$36M$25M$359M$345M
Enterprise ValueMkt cap + debt − cash$134M$32M$31M$215M$471M
Trailing P/EPrice ÷ TTM EPS-4.32x-41.72x-3.48x33.55x2.21x
Forward P/EPrice ÷ next-FY EPS est.10.90x7.16x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple2.37x3.29x
Price / SalesMarket cap ÷ Revenue102.83x0.90x0.15x0.39x0.23x
Price / BookPrice ÷ Book value/share89.51x1.57x0.43x0.62x0.44x
Price / FCFMarket cap ÷ FCF42.13x7.50x
Evenly matched — CLPS and NUS each lead in 2 of 6 comparable metrics.

Profitability & Efficiency

USNA leads this category, winning 6 of 9 comparable metrics.

NUS delivers a 20.4% return on equity — every $100 of shareholder capital generates $20 in annual profit, vs $-12 for ATPC. USNA carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to CLPS's 0.59x. On the Piotroski fundamental quality scale (0–9), USNA scores 7/9 vs CLPS's 2/9, reflecting strong financial health.

MetricATPC logoATPCAgape ATP Corpora…NHTC logoNHTCNatural Health Tr…CLPS logoCLPSCLPS IncorporationUSNA logoUSNAUSANA Health Scie…NUS logoNUSNu Skin Enterpris…
ROE (TTM)Return on equity-11.9%-4.9%-6.1%+1.8%+20.4%
ROA (TTM)Return on assets-11.1%-2.9%-3.2%+1.5%+11.3%
ROICReturn on invested capital-16.2%-6.5%-7.9%+8.6%+7.3%
ROCEReturn on capital employed-75.8%-6.1%-9.8%+8.3%+7.9%
Piotroski ScoreFundamental quality 0–922276
Debt / EquityFinancial leverage0.19x0.13x0.59x0.02x0.45x
Net DebtTotal debt minus cash-$2M-$4M$6M-$144M$126M
Cash & Equiv.Liquid assets$2M$7M$28M$158M$239M
Total DebtShort + long-term debt$362,780$3M$34M$14M$364M
Interest CoverageEBIT ÷ Interest expense50.32x15.14x
USNA leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

Evenly matched — NHTC and CLPS and NUS each lead in 2 of 6 comparable metrics.

A $10,000 investment in NHTC five years ago would be worth $9,045 today (with dividends reinvested), compared to $3 for ATPC. Over the past 12 months, NUS leads with a +26.3% total return vs ATPC's -96.8%. The 3-year compound annual growth rate (CAGR) favors CLPS at 0.2% vs ATPC's -92.3% — a key indicator of consistent wealth creation.

MetricATPC logoATPCAgape ATP Corpora…NHTC logoNHTCNatural Health Tr…CLPS logoCLPSCLPS IncorporationUSNA logoUSNAUSANA Health Scie…NUS logoNUSNu Skin Enterpris…
YTD ReturnYear-to-date-48.2%+7.1%-10.3%+0.1%-26.9%
1-Year ReturnPast 12 months-96.8%-20.7%-5.4%-31.4%+26.3%
3-Year ReturnCumulative with dividends-100.0%-5.7%+0.5%-70.7%-77.1%
5-Year ReturnCumulative with dividends-100.0%-9.6%-69.3%-80.0%-80.0%
10-Year ReturnCumulative with dividends-100.0%-63.6%-78.5%-68.7%-48.8%
CAGR (3Y)Annualised 3-year return-92.3%-1.9%+0.2%-33.6%-38.9%
Evenly matched — NHTC and CLPS and NUS each lead in 2 of 6 comparable metrics.

Risk & Volatility

Evenly matched — ATPC and NHTC each lead in 1 of 2 comparable metrics.

ATPC is the less volatile stock with a -2.01 beta — it tends to amplify market swings less than NUS's 1.49 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NHTC currently trades 53.3% from its 52-week high vs ATPC's 2.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricATPC logoATPCAgape ATP Corpora…NHTC logoNHTCNatural Health Tr…CLPS logoCLPSCLPS IncorporationUSNA logoUSNAUSANA Health Scie…NUS logoNUSNu Skin Enterpris…
Beta (5Y)Sensitivity to S&P 500-1.91x0.53x0.19x1.34x1.47x
52-Week HighHighest price in past year$119.00$6.00$1.88$38.32$14.62
52-Week LowLowest price in past year$0.07$2.40$0.80$16.60$5.65
% of 52W HighCurrent price vs 52-week peak+2.3%+53.3%+48.2%+50.8%+48.0%
RSI (14)Momentum oscillator 0–10052.757.949.859.046.4
Avg Volume (50D)Average daily shares traded2.4M25K15K118K458K
Evenly matched — ATPC and NHTC each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — NHTC and CLPS each lead in 1 of 2 comparable metrics.

Analyst consensus: USNA as "Hold", NUS as "Hold". Consensus price targets imply 79.9% upside for USNA (target: $35) vs 56.7% for NUS (target: $11). For income investors, NHTC offers the higher dividend yield at 25.04% vs NUS's 3.35%.

MetricATPC logoATPCAgape ATP Corpora…NHTC logoNHTCNatural Health Tr…CLPS logoCLPSCLPS IncorporationUSNA logoUSNAUSANA Health Scie…NUS logoNUSNu Skin Enterpris…
Analyst RatingConsensus buy/hold/sellHoldHold
Price TargetConsensus 12-month target$35.00$11.00
# AnalystsCovering analysts811
Dividend YieldAnnual dividend ÷ price+25.0%+14.6%+3.4%
Dividend StreakConsecutive years of raises030
Dividend / ShareAnnual DPS$0.80$0.13$0.24
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%0.0%+7.7%+5.8%
Evenly matched — NHTC and CLPS each lead in 1 of 2 comparable metrics.
Key Takeaway

NUS leads in 1 of 6 categories (Income & Cash Flow). USNA leads in 1 (Profitability & Efficiency). 4 tied.

Best OverallUSANA Health Sciences, Inc. (USNA)Leads 1 of 6 categories
Loading custom metrics...

ATPC vs NHTC vs CLPS vs USNA vs NUS: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is ATPC or NHTC or CLPS or USNA or NUS a better buy right now?

For growth investors, CLPS Incorporation (CLPS) is the stronger pick with 15.

2% revenue growth year-over-year, versus -14. 3% for Nu Skin Enterprises, Inc. (NUS). Nu Skin Enterprises, Inc. (NUS) offers the better valuation at 2. 2x trailing P/E (7. 2x forward), making it the more compelling value choice. Analysts rate USANA Health Sciences, Inc. (USNA) a "Hold" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — ATPC or NHTC or CLPS or USNA or NUS?

On trailing P/E, Nu Skin Enterprises, Inc.

(NUS) is the cheapest at 2. 2x versus USANA Health Sciences, Inc. at 33. 6x. On forward P/E, Nu Skin Enterprises, Inc. is actually cheaper at 7. 2x.

03

Which is the better long-term investment — ATPC or NHTC or CLPS or USNA or NUS?

Over the past 5 years, Natural Health Trends Corp.

(NHTC) delivered a total return of -9. 6%, compared to -100. 0% for Agape ATP Corporation (ATPC). Over 10 years, the gap is even starker: NUS returned -48. 4% versus ATPC's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — ATPC or NHTC or CLPS or USNA or NUS?

By beta (market sensitivity over 5 years), Agape ATP Corporation (ATPC) is the lower-risk stock at -1.

91β versus Nu Skin Enterprises, Inc. 's 1. 47β — meaning NUS is approximately -177% more volatile than ATPC relative to the S&P 500. On balance sheet safety, USANA Health Sciences, Inc. (USNA) carries a lower debt/equity ratio of 2% versus 59% for CLPS Incorporation — giving it more financial flexibility in a downturn.

05

Which is growing faster — ATPC or NHTC or CLPS or USNA or NUS?

By revenue growth (latest reported year), CLPS Incorporation (CLPS) is pulling ahead at 15.

2% versus -14. 3% for Nu Skin Enterprises, Inc. (NUS). On earnings-per-share growth, the picture is similar: Nu Skin Enterprises, Inc. grew EPS 207. 8% year-over-year, compared to -21. 7% for Agape ATP Corporation. Over a 3-year CAGR, ATPC leads at 9. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — ATPC or NHTC or CLPS or USNA or NUS?

Nu Skin Enterprises, Inc.

(NUS) is the more profitable company, earning 10. 8% net margin versus -186. 8% for Agape ATP Corporation — meaning it keeps 10. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NUS leads at 6. 1% versus -194. 5% for ATPC. At the gross margin level — before operating expenses — USNA leads at 78. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is ATPC or NHTC or CLPS or USNA or NUS more undervalued right now?

On forward earnings alone, Nu Skin Enterprises, Inc.

(NUS) trades at 7. 2x forward P/E versus 10. 9x for USANA Health Sciences, Inc. — 3. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for USNA: 79. 9% to $35. 00.

08

Which pays a better dividend — ATPC or NHTC or CLPS or USNA or NUS?

In this comparison, NHTC (25.

0% yield), CLPS (14. 6% yield), NUS (3. 4% yield) pay a dividend. ATPC, USNA do not pay a meaningful dividend and should not be held primarily for income.

09

Is ATPC or NHTC or CLPS or USNA or NUS better for a retirement portfolio?

For long-horizon retirement investors, Agape ATP Corporation (ATPC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -1.

91)). Both have compounded well over 10 years (ATPC: -100. 0%, USNA: -69. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between ATPC and NHTC and CLPS and USNA and NUS?

These companies operate in different sectors (ATPC (Consumer Defensive) and NHTC (Consumer Cyclical) and CLPS (Technology) and USNA (Consumer Defensive) and NUS (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: ATPC is a small-cap quality compounder stock; NHTC is a small-cap income-oriented stock; CLPS is a small-cap high-growth stock; USNA is a small-cap quality compounder stock; NUS is a small-cap deep-value stock. NHTC, CLPS, NUS pay a dividend while ATPC, USNA do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

ATPC

Quality Business

  • Sector: Consumer Defensive
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 31%
Run This Screen
Stocks Like

NHTC

Income & Dividend Stock

  • Sector: Consumer Cyclical
  • Market Cap > $100B
  • Gross Margin > 44%
  • Dividend Yield > 10.0%
Run This Screen
Stocks Like

CLPS

High-Growth Disruptor

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 7%
  • Gross Margin > 13%
Run This Screen
Stocks Like

USNA

Quality Business

  • Sector: Consumer Defensive
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 45%
Run This Screen
Stocks Like

NUS

Income & Dividend Stock

  • Sector: Consumer Defensive
  • Market Cap > $100B
  • Net Margin > 6%
  • Dividend Yield > 1.3%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform ATPC and NHTC and CLPS and USNA and NUS on the metrics below

Revenue Growth>
%
(ATPC: 11.9% · NHTC: -14.3%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.